9995.HK Gross Margin

The Gross Margin of RemeGen Co Ltd (9995.HK) is 9528.32%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

9995.HK Gross Margin - Historical Value

Date	Value
2020-12-31	9528.32%
2019-12-31	21.10%

9995.HK Gross Margin - Peers Comparison

Ticker	Name	Value
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	72.07%
688363.SS	Bloomage Biotechnology Corp Ltd	72.50%
6978.HK	Immunotech Biopharm Ltd	7775.20%
2181.HK	Mabpharm Ltd	84.96%
600161.SS	Beijing Tiantan Biological Products Corp Ltd	54.59%
688266.SS	Suzhou Zelgen Biopharmaceuticals Co Ltd	93.06%
9966.HK	Alphamab Oncology	90.58%
300149.SZ	ChemPartner PharmaTech Co Ltd	20.88%
9926.HK	Akeso Inc	85.82%
9939.HK	Kintor Pharmaceutical Ltd	-94.60%
603087.SS	Gan & Lee Pharmaceuticals	74.48%
1875.HK	BioDlink International Co Ltd	71.24%
2126.HK	JW (Cayman) Therapeutics Co Ltd	48.87%
300653.SZ	Yantai Zhenghai Bio-Tech Co Ltd	87.64%
4587.T	PeptiDream Inc	73.92%
688180.SS	Shanghai Junshi Biosciences Co Ltd	73.13%
688520.SS	Sinocelltech Group Ltd	95.58%
9969.HK	InnoCare Pharma Ltd	93.70%
1167.HK	Jacobio Pharmaceuticals Group Co Ltd	100.00%
002252.SZ	Shanghai RAAS Blood Products Co Ltd	40.41%
688177.SS	Bio-Thera Solutions Ltd	69.09%
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	49.08%
002007.SZ	Hualan Biological Engineering Inc	59.75%
300676.SZ	BGI Genomics Co Ltd	40.54%
6855.HK	Ascentage Pharma Group International	97.03%
000504.SZ	Landfar Bio medicine Co Ltd	67.42%
6998.HK	Genor Biopharma Holdings Ltd	99.35%
300142.SZ	Walvax Biotechnology Co Ltd	73.76%